Payment overview · 2025
General Payments
$28.97
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mina Fazli, MD
Allopathic & Osteopathic Physicians|Internal Medicine · ROCKVILLE, MD · NPI 1801966569
Verified facts
What the public records show
CMS Open Payments records show Mina Fazli, MD received $28.97 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $28.97 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $28.97 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $28.97 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 928 | 125 |
| Eliquis | Apixaban | 739 | 53 |
| Amlodipine Besylate | Amlodipine Besylate | 559 | 77 |
| Mirtazapine | Mirtazapine | 497 | 83 |
| Gabapentin | Gabapentin | 434 | 63 |
| Levothyroxine Sodium | Levothyroxine Sodium | 426 | 56 |
| Furosemide | Furosemide | 398 | 57 |
| Famotidine | Famotidine | 355 | 49 |
| Metoprolol Tartrate | Metoprolol Tartrate | 355 | 51 |
| Lisinopril | Lisinopril | 352 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 332 | 45 |
| Omeprazole | Omeprazole | 292 | 47 |
| Metoprolol Succinate | Metoprolol Succinate | 280 | 38 |
| Quetiapine Fumarate | Quetiapine Fumarate | 280 | 45 |
| Memantine Hcl | Memantine Hcl | 276 | 35 |
| Losartan Potassium | Losartan Potassium | 274 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 263 | 44 |
| Sertraline Hcl | Sertraline Hcl | 263 | 35 |
| Metformin Hcl | Metformin Hcl | 245 | 38 |
| Potassium Chloride | Potassium Chloride | 239 | 35 |
| Trazodone Hcl | Trazodone Hcl | 219 | 28 |
| Donepezil Hcl | Donepezil Hcl | 198 | 27 |
| Latanoprost | Latanoprost | 185 | 22 |
| Pantoprazole Sodium | Pantoprazole Sodium | 164 | 25 |
| Baclofen | Baclofen | 158 | 19 |
| Divalproex Sodium | Divalproex Sodium | 152 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 149 | 20 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 137 | 49 |
| Allopurinol | Allopurinol | 128 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 118 | 17 |
| Xarelto | Rivaroxaban | 118 | suppressed |
| Carvedilol | Carvedilol | 117 | 16 |
| Tradjenta | Linagliptin | 116 | suppressed |
| Finasteride | Finasteride | 115 | 15 |
| Myrbetriq | Mirabegron | 96 | suppressed |
| Levetiracetam | Levetiracetam | 94 | 13 |
| Tramadol Hcl | Tramadol Hcl | 93 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 85 | 12 |
| Buspirone Hcl | Buspirone Hcl | 82 | 11 |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 77 | 19 |
| Hydralazine Hcl | Hydralazine Hcl | 77 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 73 | 12 |
| Farxiga | Dapagliflozin Propanediol | 72 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 69 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 12 |
| Risperidone | Risperidone | 68 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 67 | suppressed |
| Aripiprazole | Aripiprazole | 66 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 66 | suppressed |
| Digoxin | Digoxin | 64 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 60 | 16 |
| Alprazolam | Alprazolam | 59 | suppressed |
| Glimepiride | Glimepiride | 59 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 59 | suppressed |
| Levofloxacin | Levofloxacin | 57 | 36 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 56 | suppressed |
| Lorazepam | Lorazepam | 56 | 14 |
| Clonazepam | Clonazepam | 54 | suppressed |
| Trulicity | Dulaglutide | 54 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 53 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 53 | 20 |
| Paroxetine Hcl | Paroxetine Hcl | 51 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 49 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 47 | 16 |
| Lidocaine Hcl | Lidocaine Hcl | 45 | 37 |
| Lubiprostone | Lubiprostone | 45 | suppressed |
| Methimazole | Methimazole | 45 | suppressed |
| Entresto | Sacubitril/Valsartan | 44 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 44 | suppressed |
| Bumetanide | Bumetanide | 43 | suppressed |
| Amantadine | Amantadine Hcl | 42 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 41 | 29 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 41 | suppressed |
| Timolol Maleate | Timolol Maleate | 41 | suppressed |
| Jardiance | Empagliflozin | 40 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 40 | suppressed |
| Spironolactone | Spironolactone | 40 | suppressed |
| Sucralfate | Sucralfate | 40 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 39 | suppressed |
| Prednisone | Prednisone | 38 | suppressed |
| Clozapine | Clozapine | 37 | suppressed |
| Lamotrigine | Lamotrigine | 37 | suppressed |
| Atenolol | Atenolol | 36 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 18 |
| Santyl | Collagenase Clostridium Hist. | 36 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 35 | suppressed |
| Nystatin | Nystatin | 35 | 22 |
| Nebivolol Hcl | Nebivolol Hcl | 34 | suppressed |
| Simvastatin | Simvastatin | 34 | suppressed |
| Insulin Lispro | Insulin Lispro | 32 | 12 |
| Januvia | Sitagliptin Phosphate | 32 | suppressed |
| Primidone | Primidone | 32 | suppressed |
| Carbamazepine Er | Carbamazepine | 30 | suppressed |
| Cephalexin | Cephalexin | 30 | 21 |
| Humalog | Insulin Lispro | 30 | suppressed |
| Irbesartan | Irbesartan | 30 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 30 | suppressed |
| Glipizide | Glipizide | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Clonidine | Clonidine | 28 | suppressed |
| Ketoconazole | Ketoconazole | 28 | 11 |
| Labetalol Hcl | Labetalol Hcl | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 18 |
| Diltiazem 24hr Er | Diltiazem Hcl | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Lactulose | Lactulose | 26 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 26 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 25 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 12 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 24 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 24 | suppressed |
| Rivastigmine | Rivastigmine | 24 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Lacosamide | Lacosamide | 23 | suppressed |
| Rytary | Carbidopa/Levodopa | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 21 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 21 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 21 | 11 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Bupropion Xl | Bupropion Hcl | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 13 |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 19 | suppressed |
| Folic Acid | Folic Acid | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 18 | suppressed |
| Ciclopirox | Ciclopirox | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Letrozole | Letrozole | 17 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 17 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Pregabalin | Pregabalin | 17 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 17 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 16 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Levemir Flexpen | Insulin Detemir | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 16 | suppressed |
| Xtandi | Enzalutamide | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 15 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 15 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | 11 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Buprenorphine | Buprenorphine | 13 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Acetylcysteine | Acetylcysteine | 12 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Klor-Con 10 | Potassium Chloride | 12 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Oxazepam | Oxazepam | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Selegiline Hcl | Selegiline Hcl | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $28.97 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error